These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7373010)

  • 1. Calcitonin serum levels in different pituitary diseases. A preliminary report.
    Ziliotto D; Luisetto G; Cecchini M; Gastaldo M; Francia G; Padovan L; Heynen G
    J Endocrinol Invest; 1980; 3(1):71-2. PubMed ID: 7373010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of pituitary hormones in cerebrospinal fluid in normal subjects and in hypothalamo-pituitary diseases. Secreting or non-secreting pituitary adenoma, empty sella syndrome, hypothalamic syndromes].
    Turpin G; Heshmati HM; Roger M; Cesselin F; Lagoguey M; Baulieu JL; De Gennes JL
    Ann Endocrinol (Paris); 1980; 41(1):21-30. PubMed ID: 7396391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors.
    Schroeder LL; Johnson JC; Malarkey WB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1255-60. PubMed ID: 1002815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
    Hong JF; Ding XH; Wang SS
    Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of hyperprolactinemia associated with hypothalamo-pituitary diseases].
    Kuwayama A; Takanohashi M; Nakane T
    Horumon To Rinsho; 1978 Mar; 26(3):255-60. PubMed ID: 647996
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary function in patients with evidence of spontaneous disappearance of a pituitary adenoma.
    Lindholm J; Bjerre P; Riishede J; Gyldensted C; Hagen C
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):599-603. PubMed ID: 6883732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man.
    Isaac R; Merceron R; Caillens G; Raymond JP; Ardaillou R
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1011-5. PubMed ID: 6768762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 9. [TSH, HGH, ACTH, LH plasma levels in patients with pituitary disease (author's transl)].
    Jaquet P; Kolaszynski Y; Oliver C; Djian R; Vague J
    Ann Endocrinol (Paris); 1973; 34(3):283-5. PubMed ID: 4356379
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum growth hormone levels in patients with brain tumors].
    Vinogradova IN; Pronina TS
    Vopr Neirokhir; 1967; 31(1):12-4. PubMed ID: 4297988
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexplained increase in serum corticosteroid-binding globulin levels in a patient with chronic thyroiditis, pituitary adenoma and empty sella.
    Tojo K; Ohno Y; Kawamura M; Sakai O
    Endocr J; 1996 Dec; 43(6):665-70. PubMed ID: 9075606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circadian behavior of blood prolactin in patients with pituitary adenoma].
    Murialdo G; Masturzo P; Rolandi E; Barreca T; Perria C
    Boll Soc Ital Biol Sper; 1978 Feb; 54(3):270-3. PubMed ID: 687435
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactin secretion in patients with chromophobe adenomas of the pituitary: incidence and presentation of hyperprolactinaemia: results of surgical treatment.
    Franks S; Nabarro JD
    Ann Clin Res; 1978; 10(3):157-63. PubMed ID: 718118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting acromegaly and primary empty sella syndrome.
    Hekimsoy Z; Yünten N; Sivrioglu S
    Neuro Endocrinol Lett; 2004 Aug; 25(4):307-9. PubMed ID: 15361823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)].
    Silvestrini F; Liuzzi A; Chiodini PG; Cattabeni A; Botalla L
    Folia Endocrinol; 1973 Oct; 26(5):398-406. PubMed ID: 4203133
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolactin of apparent large molecular size: the major immunoactive prolactin component in plasma of a patient with a pituitary tumor.
    Rogol AD; Rosen SW
    J Clin Endocrinol Metab; 1974 Apr; 38(4):714-7. PubMed ID: 4820670
    [No Abstract]   [Full Text] [Related]  

  • 17. Invasive pituitary tumor producing acromegaly, extreme elevation of growth hormone, and abnormal growth in tissue culture.
    Crowell RM; Kjellberg RN; Kliman B; Kornblith PL
    Neurochirurgia (Stuttg); 1974 Jul; 17(4):129-35. PubMed ID: 4437693
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of petrosal sinus sampling: coexisting acromegaly, empty sella and meningioma.
    Yarman S; Minareci O
    Neuroradiology; 2004 Dec; 46(12):1027-30. PubMed ID: 15580492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specificity of serum prolactin as a diagnostic indicator of pituitary adenoma.
    Balagura S; Frantz AG; Housepian EM; Carmel PW
    J Neurosurg; 1979 Jul; 51(1):42-6. PubMed ID: 448417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clomiphene in the evaluation of the pituitary-gonadal axis in acromegaly.
    Charro AL; Levin SR; Becker N; Hofeldt FD; Friedman S; Forsham PH
    J Clin Endocrinol Metab; 1973 Mar; 36(3):502-8. PubMed ID: 4685388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.